Core to Evidence-Based Health Policy
cost-effectiveness evaluation for future healthcare
C2H is the only public research organization
for official cost-effectiveness evaluation process
in Japan

C2H (Center for Outcomes Research and Economic Evaluation for Health) is an organization of National Institute of Public Health; it conducts academic analysis of cost-effectiveness evaluation from the scientific viewpoint. This website will dispatch information about cost-effectiveness evaluation in Japan. We are happy if this website contributes to evidence-based health policy (EBHP).
Tools for cost-effectiveness evaluation
Latest news
-
news
New C2H Report: Ritlecitinib tosylate (Litfulo)
Report of the cost-effectiveness evaluation on Ritlecitinib tosylate (Litfulo) was released.
-
news
New C2H Report: the aortic stent graft (The GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System)
Report of the cost-effectiveness evaluation on the aortic stent graft (The GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System) was released.
-
news
Due to server and network equipment changeover work, the website will be unavailable all day on January 18 (Sat.) and 19 (Sun.).